Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.

作者: Aurélie Morin , Eric Letouzé , Anne-Paule Gimenez-Roqueplo , Judith Favier

DOI: 10.1002/IJC.29080

关键词:

摘要: … Here, we will focus on cancer-associated mutations in … that SDH-mutated tumors have high methylation levels within … ) (Zebularine)—show cytotoxic effects at high doses. At low doses, …

参考文章(148)
Michael C. Haffner, Alcides Chaux, Alan K. Meeker, David M. Esopi, Jonathan Gerber, Laxmi G. Pellakuru, Antoun Toubaji, Pedram Argani, Christine Iacobuzio-Donahue, William G. Nelson, George J. Netto, Angelo M. De Marzo, Srinivasan Yegnasubramanian, Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers Oncotarget. ,vol. 2, pp. 627- 637 ,(2011) , 10.18632/ONCOTARGET.316
Stephan Niemann, Ulrich Müller, Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature Genetics. ,vol. 26, pp. 268- 270 ,(2000) , 10.1038/81551
J Toguchida, T Sakai, N Ohtani, D W Yandell, T P Dryja, J M Rapaport, Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. American Journal of Human Genetics. ,vol. 48, pp. 880- 888 ,(1991)
Julien Hadoux, Judith Favier, Jean-Yves Scoazec, Sophie Leboulleux, Abir Al Ghuzlan, Caroline Caramella, Désirée Déandreis, Isabelle Borget, Céline Loriot, Cécile Chougnet, Eric Letouzé, Jacques Young, Laurence Amar, Jérome Bertherat, Rosella Libé, Frédéric Dumont, Frédéric Deschamps, Martin Schlumberger, Anne Paule Gimenez-Roqueplo, Eric Baudin, SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma International Journal of Cancer. ,vol. 135, pp. 2711- 2720 ,(2014) , 10.1002/IJC.28913
Nathan L. Alderson, Yuping Wang, Matthew Blatnik, Norma Frizzell, Michael D. Walla, Timothy J. Lyons, Nadja Alt, James A. Carson, Ryoji Nagai, Suzanne R. Thorpe, John W. Baynes, S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate. Archives of Biochemistry and Biophysics. ,vol. 450, pp. 1- 8 ,(2006) , 10.1016/J.ABB.2006.03.005
S. Zhao, Y. Lin, W. Xu, W. Jiang, Z. Zha, P. Wang, W. Yu, Z. Li, L. Gong, Y. Peng, J. Ding, Q. Lei, K.-L. Guan, Y. Xiong, Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α Science. ,vol. 324, pp. 261- 265 ,(2009) , 10.1126/SCIENCE.1170944
Manel Esteller, Epigenetics in Cancer The New England Journal of Medicine. ,vol. 358, pp. 1148- 1159 ,(2008) , 10.1056/NEJMRA072067
Judith Favier, Peter Igaz, Nelly Burnichon, Laurence Amar, Rossella Libé, Cécile Badoual, Frédérique Tissier, Jérôme Bertherat, Pierre-François Plouin, Xavier Jeunemaitre, Anne-Paule Gimenez-Roqueplo, Rationale for Anti-angiogenic Therapy in Pheochromocytoma and Paraganglioma Endocrine Pathology. ,vol. 23, pp. 34- 42 ,(2012) , 10.1007/S12022-011-9189-0
Jean-Pierre Bayley, Henricus PM Kunst, Alberto Cascon, Maria Lourdes Sampietro, José Gaal, Esther Korpershoek, Adolfo Hinojar-Gutierrez, Henri JLM Timmers, Lies H Hoefsloot, Mario A Hermsen, Carlos Suárez, A Karim Hussain, Annette HJT Vriends, Frederik J Hes, Jeroen C Jansen, Carli M Tops, Eleonora P Corssmit, Peter de Knijff, Jacques WM Lenders, Cor WRJ Cremers, Peter Devilee, Winand NM Dinjens, Ronald R de Krijger, Mercedes Robledo, None, SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma Lancet Oncology. ,vol. 11, pp. 366- 372 ,(2010) , 10.1016/S1470-2045(10)70007-3